Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2

We explored the expression and function of miR-181d (microRNA-181d) in human pancreatic cancer. Quantitative real-time polymerase chain reaction was used to probe miR-181d expression in both pancreatic cancer cell lines and human pancreatic carcinoma. Pancreatic cancer cell lines, PANC-1 and AsPC-1...

Full description

Saved in:
Bibliographic Details
Main Authors: Guopeng Zhang, Dongbo Liu, Guoxian Long, Lei Shi, Hong Qiu, Guangyuan Hu, Guoqing Hu, Shunfang Liu
Format: Article
Language:English
Published: SAGE Publishing 2017-04-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317698364
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248889634291712
author Guopeng Zhang
Dongbo Liu
Guoxian Long
Lei Shi
Hong Qiu
Guangyuan Hu
Guoqing Hu
Shunfang Liu
author_facet Guopeng Zhang
Dongbo Liu
Guoxian Long
Lei Shi
Hong Qiu
Guangyuan Hu
Guoqing Hu
Shunfang Liu
author_sort Guopeng Zhang
collection DOAJ
description We explored the expression and function of miR-181d (microRNA-181d) in human pancreatic cancer. Quantitative real-time polymerase chain reaction was used to probe miR-181d expression in both pancreatic cancer cell lines and human pancreatic carcinoma. Pancreatic cancer cell lines, PANC-1 and AsPC-1 cells, were engineered to stably downregulate endogenous miR-181d through lentiviral transduction. The mechanistic effects of miR-181d downregulation on pancreatic cancer development were tested by proliferation, migration, fluorouracil chemosensitivity assays in vitro, and explant assay in vivo. Possible miR-181d downstream gene, NKAIN2 (Na+/K+ transporting ATPase interacting 2), was tested by dual-luciferase activity assay and quantitative real-time polymerase chain reaction. Functional involvement of NKAIN2 in miR-181d-regulated pancreatic cancer development was tested by small interfering RNA–mediated NKAIN2 knockdown in miR-181d-downregulated PANC-1 and AsPC-1 cells. MiR-181d was upregulated in both pancreatic cancer cell lines and human pancreatic carcinoma. Lentivirus-induced miR-181d downregulation decreased pancreatic cancer proliferation, migration, and fluorouracil resistance in vitro and inhibited the growth of cancer explant in vivo. NKAIN2 was directly targeted by miR-181d in pancreatic cancer. Small interfering RNA–mediated NKAIN2 knockdown reversed the inhibition of miR-181d downregulation on pancreatic cancer development. MiR-181d is aberrantly overexpressed in pancreatic cancer. Inhibiting miR-181d may suppress pancreatic cancer development, possibly through the inverse regulation on NKAIN2.
format Article
id doaj-art-d4dd3ce5cd1a4fbbb8326e24c017b4fa
institution Kabale University
issn 1423-0380
language English
publishDate 2017-04-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-d4dd3ce5cd1a4fbbb8326e24c017b4fa2025-08-20T03:57:43ZengSAGE PublishingTumor Biology1423-03802017-04-013910.1177/1010428317698364Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2Guopeng Zhang0Dongbo Liu1Guoxian Long2Lei Shi3Hong Qiu4Guangyuan Hu5Guoqing Hu6Shunfang Liu7Department of Nuclear Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Oncology, Affiliated Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaWe explored the expression and function of miR-181d (microRNA-181d) in human pancreatic cancer. Quantitative real-time polymerase chain reaction was used to probe miR-181d expression in both pancreatic cancer cell lines and human pancreatic carcinoma. Pancreatic cancer cell lines, PANC-1 and AsPC-1 cells, were engineered to stably downregulate endogenous miR-181d through lentiviral transduction. The mechanistic effects of miR-181d downregulation on pancreatic cancer development were tested by proliferation, migration, fluorouracil chemosensitivity assays in vitro, and explant assay in vivo. Possible miR-181d downstream gene, NKAIN2 (Na+/K+ transporting ATPase interacting 2), was tested by dual-luciferase activity assay and quantitative real-time polymerase chain reaction. Functional involvement of NKAIN2 in miR-181d-regulated pancreatic cancer development was tested by small interfering RNA–mediated NKAIN2 knockdown in miR-181d-downregulated PANC-1 and AsPC-1 cells. MiR-181d was upregulated in both pancreatic cancer cell lines and human pancreatic carcinoma. Lentivirus-induced miR-181d downregulation decreased pancreatic cancer proliferation, migration, and fluorouracil resistance in vitro and inhibited the growth of cancer explant in vivo. NKAIN2 was directly targeted by miR-181d in pancreatic cancer. Small interfering RNA–mediated NKAIN2 knockdown reversed the inhibition of miR-181d downregulation on pancreatic cancer development. MiR-181d is aberrantly overexpressed in pancreatic cancer. Inhibiting miR-181d may suppress pancreatic cancer development, possibly through the inverse regulation on NKAIN2.https://doi.org/10.1177/1010428317698364
spellingShingle Guopeng Zhang
Dongbo Liu
Guoxian Long
Lei Shi
Hong Qiu
Guangyuan Hu
Guoqing Hu
Shunfang Liu
Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2
Tumor Biology
title Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2
title_full Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2
title_fullStr Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2
title_full_unstemmed Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2
title_short Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2
title_sort downregulation of microrna 181d had suppressive effect on pancreatic cancer development through inverse regulation of knain2
url https://doi.org/10.1177/1010428317698364
work_keys_str_mv AT guopengzhang downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT dongboliu downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT guoxianlong downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT leishi downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT hongqiu downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT guangyuanhu downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT guoqinghu downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2
AT shunfangliu downregulationofmicrorna181dhadsuppressiveeffectonpancreaticcancerdevelopmentthroughinverseregulationofknain2